{"id":904549,"date":"2025-11-03T17:19:13","date_gmt":"2025-11-03T22:19:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-release-third-quarter-2025-financial-results-on-november-12\/"},"modified":"2025-11-03T17:19:13","modified_gmt":"2025-11-03T22:19:13","slug":"mdxhealth-to-release-third-quarter-2025-financial-results-on-november-12","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-release-third-quarter-2025-financial-results-on-november-12\/","title":{"rendered":"Mdxhealth to Release Third Quarter 2025 Financial Results on November 12"},"content":{"rendered":"
\n

\n Mdxhealth to Release Third Quarter 2025 Financial Results<\/strong>
\n
\n on November 12<\/strong>\n <\/p>\n

\n
\n Company to Host Conference Call with Live Q&A, November 12, 2025, at 4:30pm ET \/ 22:30 CET<\/em>
\n <\/strong>\n <\/p>\n

\n IRVINE, California <\/strong>\u2013 November 3, 2025 (GlobeNewswire<\/a>) \u2013 MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Wednesday, November 12, 2025.<\/p>\n\n\n\n\n\n\n\n
\n Title:<\/strong><\/p>\n<\/td>\nMdxhealth Presents Third Quarter 2025 Financial Results and
Corporate Update Conference Call and Webcast<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nNovember 12, 2025<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n4:30pm ET\/ 22:30 CET<\/td>\n<\/tr>\n
\n Conference Call D<\/strong>
\n ial-in <\/strong>
\n Details:<\/strong><\/p>\n<\/td>\n		\n

United States: 1-844-825-9789
Belgium: 0800 38 961
The Netherlands: 0800 94 94 506
United Kingdom: 0808 238 9064<\/p>\n<\/td>\n<\/tr>\n

\n Conference ID:<\/strong>\n <\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 10203872<\/td>\n<\/tr>\n
\n Webcast:<\/strong>\n <\/td>\n\n https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company\u2019s website.<\/p>\n

\n About Mdxhealth<\/strong>\n <\/p>\n

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company\u2019s tests are based on proprietary genomic, epigenomic, exosomal and other molecular signatures and assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. The Company\u2019s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Waltham, Massachusetts and Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com\/mdxhealth, facebook.com\/mdxhealth and linkedin.com\/company\/mdxhealth.<\/p>\n\n\n\n
\n For more information:<\/strong>
\n
\n ir@mdxhealth.com<\/a>
\n
\n LifeSci Advisors (IR & PR)<\/strong>
\n
\n John Fraunces<\/strong>
\n
\n Managing Director<\/strong>
\n
Tel: +1 917 355 2395
Jfraunces@lifesciadvisors.com<\/a><\/p>\n<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n Attachment<\/strong>\n <\/p>\n